{"title":"Bridging the gap: overcoming anatomical challenges in kidney transplantation with prosthetic grafts.","authors":"Hyung Sub Park","doi":"10.4174/astr.2026.111.3.131","DOIUrl":"10.4174/astr.2026.111.3.131","url":null,"abstract":"","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 3","pages":"131-132"},"PeriodicalIF":2.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13574519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148966282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yoon Soo Chae, Youngmin Han, Seulah Park, Go-Won Choi, Younsoo Seo, Inhyuck Lee, Hye-Sol Jung, Young Jae Cho, Wooil Kwon, Jin-Young Jang, Joon Seong Park
{"title":"Clinical benefit of adjuvant chemotherapy in resected T2N0 distal cholangiocarcinoma: a retrospective cohort study.","authors":"Yoon Soo Chae, Youngmin Han, Seulah Park, Go-Won Choi, Younsoo Seo, Inhyuck Lee, Hye-Sol Jung, Young Jae Cho, Wooil Kwon, Jin-Young Jang, Joon Seong Park","doi":"10.4174/astr.2026.111.3.139","DOIUrl":"10.4174/astr.2026.111.3.139","url":null,"abstract":"<p><strong>Purpose: </strong>Several studies have reported that adjuvant chemotherapy (AC) improves survival outcomes in patients with distal cholangiocarcinoma (dCCA). However, definitive evidence supporting the efficacy of AC in dCCA patients with early T-stage and node-negative disease remains lacking. This study aimed to investigate the clinical benefit of AC and prognostic factors in patients with the early stage of dCCA, with a focus on resected T2N0 dCCA.</p><p><strong>Methods: </strong>A total of 123 patients who underwent curative surgery with pathological confirmation of T2N0 dCCA between 2000 and 2022 were reviewed using prospectively collected clinicopathologic data.</p><p><strong>Results: </strong>No significant between-group differences were observed in 5-year overall survival (OS) (64.8% <i>vs.</i> 68.5%, P = 0.247) and recurrence-free survival (RFS) (54.6% <i>vs.</i> 59.4%, P = 0.317). Furthermore, no significant differences were observed in locoregional RFS (71.7% <i>vs.</i> 75.5%, P = 0.269) and distant metastasis-free survival (71.7% <i>vs.</i> 76.5%, P = 0.414). Multivariate analysis revealed that the effect of AC was not meaningful and only R1 resection was an independent negative prognostic factor for both OS and RFS. In subgroup analysis, neither AC nor adjuvant radiotherapy was associated with survival outcomes in the R1 resection group.</p><p><strong>Conclusion: </strong>Routine use of AC did not significantly improve postoperative survival outcomes in patients with completely resected T2N0 dCCA, nor was its clinical benefit remarkably even in the high-risk group (positive resection margins). Therefore, achieving an R0 resection appears to be more important for improving postoperative survival outcomes in T2N0 dCCA.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 3","pages":"139-147"},"PeriodicalIF":2.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13574522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148966315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seijong Kim, Dae Hee Pyo, Jaeim Lee, Chang Hyun Kim, Heung-Kwon Oh, Yoon Suk Lee, Yong Sik Yoon, Dong Hwan Bae, Byung Soh Min, Jung Wook Huh
{"title":"Learning curve analysis of laparoscopic low anterior resection using the ArtiSential multi-articulating device: a multicenter retrospective cohort study with pooled analysis (STARC trial).","authors":"Seijong Kim, Dae Hee Pyo, Jaeim Lee, Chang Hyun Kim, Heung-Kwon Oh, Yoon Suk Lee, Yong Sik Yoon, Dong Hwan Bae, Byung Soh Min, Jung Wook Huh","doi":"10.4174/astr.2026.111.3.164","DOIUrl":"10.4174/astr.2026.111.3.164","url":null,"abstract":"<p><strong>Purpose: </strong>Robotic surgery has shown promising outcomes in colorectal cancer treatment but is limited by its high cost. In response, the ArtiSential system (LivsMed Inc.), an articulated handheld laparoscopic instrument, has emerged as an alternative. This study aimed to assess the learning curve associated with ArtiSential during low anterior resection (LAR) of colorectal cancer.</p><p><strong>Methods: </strong>A multicenter retrospective cohort study enrolled 208 patients who underwent LAR with ArtiSential between January 2021 and October 2022. A cumulative sum (CUSUM) analysis was conducted for operation time. Three experienced surgeons, each with over 30 completed ArtiSential-assisted LAR procedures, were included in the analysis.</p><p><strong>Results: </strong>The median operation time was 129 minutes; it was accompanied by minimal blood loss and no open conversions. Pathological analysis revealed favorable outcomes with high-quality total mesorectal excision and a circumferential resection margin. Surgeons A and B followed a conventional 4-stage learning curve, achieving mastery after 25 and 24 cases, respectively. In contrast, surgeon C demonstrated a unique 2-stage learning curve, achieving mastery after 19 cases.</p><p><strong>Conclusion: </strong>The CUSUM analysis suggests a relatively manageable learning curve, with the initial phase being completed after approximately 10 cases and proficiency attained after 20-30 cases. In conclusion, ArtiSential appears to be a promising tool for colorectal surgeons, offering a favorable learning curve and encouraging outcomes in LAR for rectal cancer.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 3","pages":"164-169"},"PeriodicalIF":2.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13574520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148966406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ara Cho, Sungsin Cho, Ahram Han, Sangil Min, Jongwon Ha
{"title":"Dacron vascular grafts: a long-term solution for short renal vein challenges in living donor kidney transplantation in a retrospective case series.","authors":"Ara Cho, Sungsin Cho, Ahram Han, Sangil Min, Jongwon Ha","doi":"10.4174/astr.2026.111.3.177","DOIUrl":"10.4174/astr.2026.111.3.177","url":null,"abstract":"<p><strong>Purpose: </strong>Short renal veins in living donor kidney transplantation present technical challenges during graft placement and vascular anastomosis. Artificial graft use raises concerns about infection and thrombosis. We share our experiences using Dacron vascular grafts (Hemagard, Maquet) for renal vein extension with long-term safety and efficacy.</p><p><strong>Methods: </strong>We retrospectively reviewed 11 cases at Seoul National University Hospital (2016-2024) where Dacron vascular grafts were used for renal vein extension. Patient demographics, comorbidities, graft size, and postoperative antiplatelet therapy were analyzed. Imaging follow-up was performed with sonography before discharge.</p><p><strong>Results: </strong>Patients had a median age of 56 years and a median body mass index of 25.0 kg/m<sup>2</sup>. Eight grafts involved the right kidney and three involved the left kidney. The median graft diameter was 12 mm. At discharge, median serum creatinine was 1.2 mg/dL and median estimated glomerular filtration rate was 63.7 mL/min/1.73 m<sup>2</sup>. Median follow-up was 46 months. One patient required reoperation due to bleeding unrelated to the graft. No thrombosis or stenosis was detected. Vascular patency was excellent in all cases during follow-up, aside from 1 death (pneumonia) and 1 graft failure from immunoglobulin A nephropathy recurrence.</p><p><strong>Conclusion: </strong>Dacron vascular grafts for renal vein extension in living donor kidney transplantation are a reliable and effective surgical option, demonstrating favorable long-term safety and patency without increased thrombotic or infectious complications under antiplatelet management.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 3","pages":"177-182"},"PeriodicalIF":2.0,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13574518/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148966389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Moon Young Oh, Hyejin Hong, Mira Han, Borim Ryu, Young Jun Chai
{"title":"Preoperative predictors of occult central lymph node metastasis in clinically node-negative papillary thyroid carcinoma: a common data model-based retrospective cohort study.","authors":"Moon Young Oh, Hyejin Hong, Mira Han, Borim Ryu, Young Jun Chai","doi":"10.4174/astr.2026.111.2.69","DOIUrl":"10.4174/astr.2026.111.2.69","url":null,"abstract":"<p><strong>Purpose: </strong>In papillary thyroid carcinoma (PTC), central lymph node metastasis (CLNM) is frequently detected only after surgery, even when preoperative ultrasonography (USG) and CT show no suspicious lymph nodes. Identifying readily available clinical factors associated with occult CLNM may guide the decision for prophylactic central neck dissection in clinically node-negative (cN0) PTC. We investigated factors associated with CLNM using a Common Data Model (CDM)-based cohort.</p><p><strong>Methods: </strong>Patients who underwent thyroid surgery for PTC between 2013 and 2022 and had no suspected nodal metastasis on preoperative USG or CT were included. Demographic and laboratory variables were extracted from the CDM database. Univariable and multivariable logistic regression analyses were performed to identify factors independently associated with CLNM.</p><p><strong>Results: </strong>A total of 1,020 patients (246 males, 774 females) were included. The mean age was 50.1 ± 13.2 years. CLNM was identified in 313 patients (30.7%). On multivariable analysis, male sex (adjusted odds ratio [aOR], 1.548; 95% confidence interval [CI], 1.138-2.106; P = 0.005) was independently associated with CLNM, whereas age ≥55 years was inversely associated (aOR, 0.687; 95% CI, 0.515-0.915; P = 0.010). Compared with tumors ≤1 cm, tumor size 1-2 cm (aOR, 2.231; 95% CI, 1.649-3.018; P < 0.001) and >2 cm (aOR, 2.739; 95% CI, 1.711-4.383; P < 0.001) were associated with higher odds of CLNM.</p><p><strong>Conclusion: </strong>In cN0 PTC, male sex, younger age, and larger tumor size were independently associated with occult CLNM. These factors may help identify patients who warrant closer consideration for central neck management despite negative preoperative imaging.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 2","pages":"69-76"},"PeriodicalIF":2.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13457781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148711115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jiyoung Baik, Hayeon Do, Suk Min Gwon, Youngju Ryu, Eunjin Lee, Namkee Oh, Jinsoo Rhu, Gyu-Seong Choi, Jongman Kim
{"title":"Comprehensive comparative analysis of eight predictive indices for survival after deceased donor liver transplantation: a retrospective cohort study.","authors":"Jiyoung Baik, Hayeon Do, Suk Min Gwon, Youngju Ryu, Eunjin Lee, Namkee Oh, Jinsoo Rhu, Gyu-Seong Choi, Jongman Kim","doi":"10.4174/astr.2026.111.2.111","DOIUrl":"10.4174/astr.2026.111.2.111","url":null,"abstract":"<p><strong>Purpose: </strong>Deceased donor liver transplantation (DDLT) remains constrained by organ shortages, emphasizing the need for accurate predictive models to optimize allocation and improve outcomes. Although multiple indices, such as Model for End-Stage Liver Disease (MELD), MELD-Na, and donor-specific models, exist to predict recipient and graft survival, their comparative performance remains uncertain.</p><p><strong>Methods: </strong>This study compared 8 predictive models (MELD, MELD-Na, Gender-Equity Model for Liver Allocation [GEMA], GEMA-Na, Donor Rejection Organ Procurement Evaluation, Donor Risk Index, Kidney Donor Profile Index [KDPI], and Korean KDPI) in predicting overall and graft survival after DDLT. Data from 328 donor-recipient pairs at Samsung Medical Center (2000-2020) were retrospectively analyzed. Calibration was assessed using the Hosmer-Lemeshow test and R<sup>2</sup> values, and discrimination using the Kaplan-Meier curves, concordance statistics (c-index), and receiver operating characteristic curves.</p><p><strong>Results: </strong>MELD-Na demonstrated the highest calibration and discrimination for both overall and graft survival, particularly at short-term follow-up. Recipient-based models (MELD, GEMA) showed satisfactory performance, with MELD closely following MELD-Na in predicting overall survival. In contrast, donor-based indices (KDPI, K-KDPI) exhibited weak predictive power. Integrating recipient and donor parameters improved the overall comprehensiveness of prediction.</p><p><strong>Conclusion: </strong>MELD-Na is the most reliable predictor of short-term survival after DDLT. Donor-specific indices provide valuable insights into organ quality but are limited in survival prediction. Integrating both donor and recipient factors may refine organ allocation and enhance posttransplant outcomes. Further validation across diverse populations and the incorporation of advanced technologies, including machine learning, are warranted to optimize predictive accuracy in liver transplantation.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 2","pages":"111-121"},"PeriodicalIF":2.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13457793/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148711315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jiwon Yu, Sunghae Park, Gyu-Seong Choi, Jongman Kim, Namkee Oh, Bogeun Kim, Jinsoo Rhu
{"title":"Prediction model for hypertrophied liver volume followed by hemihepatectomy: a retrospective cohort study.","authors":"Jiwon Yu, Sunghae Park, Gyu-Seong Choi, Jongman Kim, Namkee Oh, Bogeun Kim, Jinsoo Rhu","doi":"10.4174/astr.2026.111.2.86","DOIUrl":"10.4174/astr.2026.111.2.86","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to develop a statistical model for predicting hypertrophied future liver remnant volume (HFLRV) in patients with right hemihepatectomy (RHH).</p><p><strong>Methods: </strong>Patients who underwent RHH at Samsung Medical Center between January 2022 and March 2024 were included in this study. Liver volume was calculated from abdomen CT by using a deep learning-based volumetric tool.</p><p><strong>Results: </strong>A total of 98 patients were included. There were 58 and 40 patients whose liver regeneration index was less than 0.8 and 0.8 or more, respectively. The prediction model, which focused on identifying variables associated with HFLRV, included age at diagnosis (P = 0.14), sex (P = 0.01), both preoperative hemi-liver volumes (P < 0.001), and international normalized ratio (P < 0.05). This model demonstrated adjusted R<sup>2</sup> of 0.60, correlation coefficient (r) of 0.78, and P-value of <0.001.</p><p><strong>Conclusion: </strong>This study developed a linear prediction model for HFLRV and determined which factors can be used to predict HFLRV before RHH.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 2","pages":"86-92"},"PeriodicalIF":2.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13457784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148711292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A preliminary experimental study of venoactive compounds on human lymphatic endothelial cells: cellular response and therapeutic potential.","authors":"Hyunmin Ko","doi":"10.4174/astr.2026.111.2.122","DOIUrl":"10.4174/astr.2026.111.2.122","url":null,"abstract":"<p><strong>Purpose: </strong>Lymphedema is a common complication following surgical procedures, particularly in breast cancer patients. However, no effective medical treatment has been clearly established. Venoactive compounds (venoactive drugs, VADs) are frequently used as an alternative option, despite limited supporting evidence. This study aimed to evaluate their potential therapeutic role in lymphedema.</p><p><strong>Methods: </strong>Human lymphatic endothelial cells (HLECs) were used to assess the effects of diosmin, calcium dobesilate, and <i>Vitis vinifera</i> extract. Cell viability was evaluated using the MTT assay to determine non-cytotoxic concentrations. Lymphangiogenesis was assessed using Transwell migration and Matrigel-based tube formation assays (Corning). Western blot analysis was performed to examine the activation of protein kinase B (AKT), extracellular signal-regulated kinase (ERK), and p38 mitogen-activated protein kinase (MAPK) signaling pathways.</p><p><strong>Results: </strong>Treatment with VADs showed an overall tendency to suppress cell migration compared to the control. On the other hand, there was no significant difference in the tube formation. Western blot analysis revealed that <i>Vitis vinifera</i> extract significantly inhibited the activation of AKT, ERK, and p38 MAPK pathways. Diosmin increased p38 activation without affecting AKT or ERK, while calcium dobesilate did not induce any significant changes in these signaling pathways.</p><p><strong>Conclusion: </strong>VADs did not directly promote lymphangiogenesis in HLECs. Their therapeutic effects in lymphedema may instead be mediated by microvascular stabilization through anti-inflammatory, antioxidant, and permeability-reducing mechanisms. Further experimental and clinical studies are needed to validate these findings.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 2","pages":"122-130"},"PeriodicalIF":2.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13457780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148711328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yoon Kong, Ja Kyung Lee, Sukmin Yun, Eunji Kim, Jae Bong Choi, Hyeong Won Yu, June Young Choi
{"title":"Comparison of four commercially available adhesion barriers after open thyroid surgery: a prospective observational study.","authors":"Yoon Kong, Ja Kyung Lee, Sukmin Yun, Eunji Kim, Jae Bong Choi, Hyeong Won Yu, June Young Choi","doi":"10.4174/astr.2026.111.2.77","DOIUrl":"10.4174/astr.2026.111.2.77","url":null,"abstract":"<p><strong>Purpose: </strong>Postoperative cervical adhesions after thyroidectomy can lead to neck tightness, dysphagia, and cosmetic dissatisfaction, but the clinical benefits of antiadhesion agents remain unclear. This study compared the efficacy and safety of four commercially available antiadhesion agents applied after open thyroid surgery.</p><p><strong>Methods: </strong>This singlecenter prospective observational study at a tertiary care hospital included included patients aged 20-70 years undergoing their first open thyroid surgery with intraoperative application of 1 of 4 agents: MegaShield (MS; L&C Bio Co., Ltd.), MegaDerm (MD; L&C Bio Co., Ltd.), CollaBarrier (CB; Dalim Tissen Co., Ltd.), or ACE COL (AC; Korea BNC Co., Ltd. and IreBio Co., Ltd.). Two units were applied at the tracheal bed and subcutaneous layer at the end of surgery. A 7item adhesion questionnaire and the Vancouver Scar Scale (VSS) were assessed at 2 and 12 weeks postoperatively by an independent evaluator. Adverse events were recorded at each visit. Group differences were analyzed using nonparametric tests.</p><p><strong>Results: </strong>Of 200 enrolled patients, 180 completed followup (MS, 46; MD, 45; CB, 47; and AC, 42). Baseline characteristics were comparable. Adhesion scores increased at 2 weeks and improved by 12 weeks in all groups, with no significant betweengroup differences at any time point. VSS total scores showed a similar pattern, with only a transiently higher pigmentation score at 2 weeks in the MS group; no differences persisted at 12 weeks. Complication rates were low and similar across groups.</p><p><strong>Conclusion: </strong>Four different antiadhesion agents demonstrated comparable shortterm efficacy for adhesionrelated symptoms and scar quality after open thyroid surgery, with no clinically meaningful superiority of any single agent. All products were well tolerated.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 2","pages":"77-85"},"PeriodicalIF":2.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13457789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148711325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect of endoscopic submucosal dissection on short-term surgical outcome after radical gastrectomy: a multicenter retrospective study based on the Korean Gastric Cancer Association nationwide survey.","authors":"Jinjoo Kim, Ki Bum Park, Han Hong Lee","doi":"10.4174/astr.2026.111.2.101","DOIUrl":"10.4174/astr.2026.111.2.101","url":null,"abstract":"<p><strong>Purpose: </strong>Endoscopic submucosal dissection (ESD) is a minimally invasive treatment for early gastric cancer (EGC) with a low risk of lymph node metastasis. However, 17%-21% of patients require additional curative gastrectomy (ACG) due to non-curative factors. Although ESD may induce fibrosis or adhesions that could complicate subsequent surgery, its impact on surgical outcomes after ACG remains unclear. This study aimed to evaluate the impact of prior ESD on postoperative outcomes following ACG.</p><p><strong>Methods: </strong>We retrospectively analyzed national data from the Korean Gastric Cancer Association, including 11,594 patients with EGC who underwent gastrectomy between January 2019 and December 2019. Of these, 913 patients underwent ACG after non-curative ESD, while 10,681 underwent primary gastrectomy. Outcomes were compared between the ACG and surgery-only groups using 1:1 propensity score matching.</p><p><strong>Results: </strong>A total of 1,826 matched patients were analyzed, with 913 patients in each group. There was no significant difference in severe complication rates (Clavien-Dindo grade ≥III) between the post-ESD group and the surgery-only group (4.4% <i>vs.</i> 5.3%, P = 0.986). Operative time, blood loss, and 30-day mortality were also comparable between groups. Higher body mass index (odds ratio [OR], 1.069; P = 0.043) and total gastrectomy (OR, 2.088; P = 0.006) were associated with an increased risk of severe complications.</p><p><strong>Conclusion: </strong>This study is the first to use national data to evaluate surgical outcomes after ACG following non-curative ESD. The results suggest that prior ESD does not adversely affect postoperative outcomes, providing evidence to guide surgical decision-making in patients with EGC requiring ACG.</p>","PeriodicalId":8071,"journal":{"name":"Annals of Surgical Treatment and Research","volume":"111 2","pages":"101-110"},"PeriodicalIF":2.0,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13457782/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148711287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}